Terms: = Gastric cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
21 results:
1. Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and Prognosis in gastric cancer.
An S; Li X; Li B; Li Y
Comb Chem High Throughput Screen; 2023; 26(3):527-538. PubMed ID: 35570548
[TBL] [Abstract] [Full Text] [Related]
2. Anti-gastric cancer Effect of Purified
Xu Y; Xu W; Lu Z; Cheung MH; Lin M; Liang C; Lou J; Chen Y
Nutr Cancer; 2022; 74(5):1780-1791. PubMed ID: 34601984
[TBL] [Abstract] [Full Text] [Related]
3. Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy.
Ishii T; Suzuki A; Kuwata T; Hisamitsu S; Hashimoto H; Ohara Y; Yanagihara K; Mitsunaga S; Yoshino T; Kinoshita T; Ochiai A; Shitara K; Ishii G
Gastric Cancer; 2021 Jul; 24(4):810-822. PubMed ID: 33837489
[TBL] [Abstract] [Full Text] [Related]
4. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
[No Abstract] [Full Text] [Related]
5. Mapping a Circular RNA-microRNA-mRNA-Signaling Regulatory Axis That Modulates Stemness Properties of cancer Stem Cell Populations in Colorectal cancer Spheroid Cells.
Rengganaten V; Huang CJ; Tsai PH; Wang ML; Yang YP; Lan YT; Fang WL; Soo S; Ong HT; Cheong SK; Choo KB; Chiou SH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114016
[TBL] [Abstract] [Full Text] [Related]
6. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
Chu Y; Xu B; Song Q; Hu Q
Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805
[TBL] [Abstract] [Full Text] [Related]
7. Broadening horizons with
Ballal S; Yadav MP; Bal C; Sahoo RK; Tripathi M
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):934-946. PubMed ID: 31707430
[TBL] [Abstract] [Full Text] [Related]
8. Repurposing the selective estrogen receptor modulator
Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
[TBL] [Abstract] [Full Text] [Related]
9. [Analysis of biological characteristics and prognosis on gastrointestinal stromal tumor with PDGFRA gene mutation].
Qi C; Pan F; Li J; Li Y; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1280-1284. PubMed ID: 30506540
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early gastric cancer.
Yu L; Wu D; Gao H; Balic JJ; Tsykin A; Han TS; Liu YD; Kennedy CL; Li JK; Mao JQ; Tan P; Oshima M; Goodall GJ; Jenkins BJ
Clin Cancer Res; 2018 Mar; 24(6):1459-1472. PubMed ID: 29330205
[No Abstract] [Full Text] [Related]
11. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.
West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ
Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875
[TBL] [Abstract] [Full Text] [Related]
12. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract] [Full Text] [Related]
13. Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.
Iacovelli R; Pietrantonio F; Maggi C; de Braud F; Di Bartolomeo M
Crit Rev Oncol Hematol; 2016 Feb; 98():24-8. PubMed ID: 26481953
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.
Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS
PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649
[TBL] [Abstract] [Full Text] [Related]
15. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract] [Full Text] [Related]
16. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M
Cancer Cell; 2013 Aug; 24(2):257-71. PubMed ID: 23948300
[TBL] [Abstract] [Full Text] [Related]
17. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract] [Full Text] [Related]
18. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice.
Thiem S; Pierce TP; Palmieri M; Putoczki TL; Buchert M; Preaudet A; Farid RO; Love C; Catimel B; Lei Z; Rozen S; Gopalakrishnan V; Schaper F; Hallek M; Boussioutas A; Tan P; Jarnicki A; Ernst M
J Clin Invest; 2013 Feb; 123(2):767-81. PubMed ID: 23321674
[TBL] [Abstract] [Full Text] [Related]
19. IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines.
Mejías-Luque R; Peiró S; Vincent A; Van Seuningen I; de Bolós C
Biochim Biophys Acta; 2008 Oct; 1783(10):1728-36. PubMed ID: 18573283
[TBL] [Abstract] [Full Text] [Related]
20. Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.
Zhu X; Leaw J; Gu W; Qian Y; Du H; Wang B; Hong X; Yin J
J Cancer Res Clin Oncol; 2008 Sep; 134(9):929-36. PubMed ID: 18343948
[TBL] [Abstract] [Full Text] [Related]
[Next]
